NCT02743078 · Interventional trial
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma
Overall registry status Terminated
Phase 2
Conditions Glioblastoma, Glioma, Gliosarcoma
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory